Physician
Internal Medicine
Dr. Geoffrey T. Gibney, MD
|
|
Give Review
Geoffrey Gibney is an expert in the field of Internal Medicine. He researched medicine at University of Connecticut School of Medicine. University of Connecticut School of Medicine is ranked 60 in research and 49 in primary care medicine Geoffrey T. Gibney, MD is a published doctor and has 28 publications published. The lastest was: 'BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy.' Geoffrey Gibney accepts Medicare payments and is registered with Medicare.gov.
Publications
- Clinical outcomes of melanoma Brain metastases treated with stereotactic radiation and anti-PD-1 therapy.
- Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes.
- BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy.
- Ligand-Independent EPHA2 Signaling Drives the Adoption of a Targeted Therapy-Mediated Metastatic Melanoma Phenotype.
- Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma.
- Phosphoproteomic Analysis of basal and therapy-induced adaptive signaling networks in BRAF and NRAS mutant melanoma.
- LINAC-based stereotactic radiosurgery to the Brain with concurrent vemurafenib for melanoma metastases.
- Vertical inhibition of the MAPK pathway enhances therapeutic responses in NRAS-mutant melanoma.
- Indications and Options for Systemic Therapy in Melanoma.
- Beyond BRAF: where next for melanoma therapy?
- Amuvatinib has cytotoxic effects against NRAS-mutant melanoma but not BRAF-mutant melanoma.
- Setting the bar for adjuvant treatment of melanoma.
- Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma.
- Long-term effects of BRAF inhibitors in melanoma treatment: friend or foe?
- Conjunctival Melanomas Harbor BRAF and NRAS Mutations--Letter.
- Novel treatments for melanoma Brain metastases.
- Recent advances in the treatment of melanoma.
- Paradoxical oncogenesis-the long-term effects of BRAF inhibition in melanoma.
- Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies.
- c-Met is a prognostic marker and potential therapeutic target in clear Cell renal Cell carcinoma.
- Is HbA(2) level a reliable diagnostic measurement for ?-thalassemia trait in people with iron deficiency?
- Variation and heritability of Hb F and F-Cells among beta-thalassemia heterozygotes in Hong Kong.
- Neuroprotective role of delta-opioid receptors in cortical neurons.
- Integrating molecular biomarkers into current clinical management in melanoma.
- Effect of prolonged hypoxia on Na+ channel mRNA subtypes in the developing rat cortex.
- Na(+)/Ca(2+) exchanger expression in the developing rat cortex.
- Effect of protein kinases on lactate dehydrogenase activity in cortical neurons during hypoxia.
Schools
Univ Of Ct Sch Of Med
Boston University Medical CenterInternal Medicine
Yale UniversityYale Cancer CenterHematologyMedical Oncology
Bs Tufts University 2000Biochemistry
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
Education
-
Yale-New Haven Hospital -
Boston University Medical Center -
University of Connecticut School of Medicine
Hospital
-
Tampa General Hospital -
H. Lee Moffitt Cancer Center and Research Institute
Drug Facts
| NPI NUMBER | 1164696878 | |
| NPPES Provider LastName | GIBNEY | |
| NPPES Provider FirstName | GEOFFREY | |
| NPPES Provider ZIPCode | 336129416 | |
| NPPES Provider State | FL | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 318.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 42.0 | |
| Percent Opioid Claims | 13.21 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164696878 |
| Last Name Of The Provider | GIBNEY |
| First Name Of The Provider | GEOFFREY |
| View All |
Similar Doctors
|
Dr. Carolyn M. Schlede, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Mayra M. Rivera, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bishoy T. Samuel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca A. Piotrowski, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lachara V. Livingston, MD |
|
|
Dr. Nazeer H. Khan, MD |
|
|
Dr. Ayesha S. Farooq, MD |
|
|
Dr. Michael C. Burnette, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Y K Peter Park, MD |
|
|
Dr. John D. Accomando, MD
This Doctor is OpenDoctor Recommended.
|